NO20003723D0 - Triazol- og imidazolderivater - Google Patents

Triazol- og imidazolderivater

Info

Publication number: NO20003723D0
Authority: NO; Norway
Prior art keywords: triazole; imidazole derivatives; imidazole; derivatives
Prior art date: 1999-07-21

Application number

NO20003723A

Other languages

English (en)

Other versions

NO20003723L (no

Inventor

Alexander Alanine

Bernd Buettelmann

Neidhart Marie-Paule Heitz

Georg Jaescke

Emmanuel Pinard

Rene Wyler

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-21

Filing date

2000-07-20

Publication date

2000-07-20

2000-07-20 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2000-07-20 Publication of NO20003723D0 publication Critical patent/NO20003723D0/no

2001-01-22 Publication of NO20003723L publication Critical patent/NO20003723L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

NO20003723A 1999-07-21 2000-07-20 Triazol- og imidazolderivater NO20003723L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99114313		1999-07-21

Publications (2)

Publication Number	Publication Date
NO20003723D0 true NO20003723D0 (no)	2000-07-20
NO20003723L NO20003723L (no)	2001-01-22

Family

ID=8238635

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20003723A NO20003723L (no)	1999-07-21	2000-07-20	Triazol- og imidazolderivater

Country Status (29)

Country	Link
US (1)	US6265426B1 (no)
EP (1)	EP1070708B1 (no)
JP (1)	JP3628946B2 (no)
KR (1)	KR100383776B1 (no)
CN (1)	CN1148357C (no)
AR (1)	AR024790A1 (no)
AT (1)	ATE257827T1 (no)
AU (1)	AU773463B2 (no)
BR (1)	BR0003075A (no)
CA (1)	CA2314009C (no)
CO (1)	CO5190713A1 (no)
DE (1)	DE60007697T2 (no)
DK (1)	DK1070708T3 (no)
ES (1)	ES2211420T3 (no)
HR (1)	HRP20000482A2 (no)
HU (1)	HUP0002792A3 (no)
ID (1)	ID26599A (no)
IL (1)	IL137328A0 (no)
MA (1)	MA26747A1 (no)
MX (1)	MXPA00007069A (no)
NO (1)	NO20003723L (no)
NZ (1)	NZ505766A (no)
PE (1)	PE20010349A1 (no)
PL (1)	PL341616A1 (no)
PT (1)	PT1070708E (no)
SG (1)	SG98422A1 (no)
TR (1)	TR200002097A3 (no)
UY (1)	UY26253A1 (no)
ZA (1)	ZA200003680B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5962490A (en) *	1987-09-25	1999-10-05	Texas Biotechnology Corporation	Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6610723B2 (en) *	2001-01-29	2003-08-26	Hoffmann-La Roche Inc.	Imidazole derivatives
WO2002072542A2 (en) *	2001-03-08	2002-09-19	Emory University	Ph-dependent nmda receptor antagonists
US6951875B2 (en) *	2001-10-29	2005-10-04	Hoffmann-La Roche Inc.	Conjugated aromatic compounds with a pyridine substituent
US7005432B2 (en) *	2002-05-16	2006-02-28	Hoffman-La Roche Inc.	Substituted imidazol-pyridazine derivatives
JP2005533058A (ja)	2002-06-17	2005-11-04	メルク　エンド　カムパニー　インコーポレーテッド	Ｅｄｇ受容体アゴニストとしての１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）アゼチジン−３−カルボキシラートおよび１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）ピロリジン−３−カルボキシラート
JP2006515276A (ja) *	2002-10-22	2006-05-25	オスコテック株式会社	骨粗鬆症の予防及び治療効果を有するフラン誘導体並びにこれを含む薬学的組成物
US7084145B2 (en) *	2002-10-25	2006-08-01	Pfizer Inc.	Triazole compounds useful in therapy
JP2006518738A (ja) *	2003-02-12	2006-08-17	トランス　テック　ファーマ，インコーポレイテッド	治療薬としての置換アゾール誘導体
GB0303503D0 (en) *	2003-02-14	2003-03-19	Novartis Ag	Organic compounds
GB0315111D0 (en)	2003-06-27	2003-07-30	Cancer Rec Tech Ltd	Substituted 5-membered ring compounds and their use
AU2004309357B2 (en) *	2003-12-22	2010-10-07	Merck Sharp & Dohme Corp.	Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
US20050187277A1 (en) *	2004-02-12	2005-08-25	Mjalli Adnan M.	Substituted azole derivatives, compositions, and methods of use
AU2007211319B9 (en)	2006-01-30	2012-05-31	Vtv Therapeutics Llc	Substituted imidazole derivatives and their use as PTPase inhibitors
JO3019B1 (ar) *	2006-04-19	2016-09-05	Janssen Pharmaceutica Nv	ثلاثي مستبدل 4،2،1-ثلاثي زولات
CN101679319B (zh)	2007-02-08	2014-07-09	辛塔医药品有限公司	用于治疗增生性病症如癌症的三唑类化合物
JP5580732B2 (ja)	2007-04-03	2014-08-27	イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー	置換ベンゼン殺菌・殺カビ剤
WO2008131148A1 (en) *	2007-04-19	2008-10-30	The Trustees Of The University Of Pennsylvania	Diphenyl-heteroaryl derivatives and their use for binding and imaging amyloid plaques
CN103058957A (zh)	2007-06-29	2013-04-24	埃莫里大学	用于神经保护的nmda受体拮抗剂
JP2011500625A (ja)	2007-10-18	2011-01-06	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	トリ置換された１，２，４−トリアゾール
JO2784B1 (en)	2007-10-18	2014-03-15	شركة جانسين فارماسوتيكا ان. في	5,3,1 - Triazole substitute derivative
MY152486A (en)	2008-03-19	2014-10-15	Janssen Pharmaceutica Nv	Trisubstituted 1,2,4 - triazoles as nicotinic acetylcholine receptor modulators
MX2010009649A (es) *	2008-03-27	2010-12-17	Evotecv Neurosciences Gmbh	Metodos para tratar trastornos utilizando un antagonista selectivo del subtipo nr2b de nmda.
WO2009135944A1 (en)	2008-05-09	2009-11-12	Janssen Pharmaceutica Nv	Trisubstituted pyrazoles as acetylcholine receptor modulators
RU2532394C1 (ru) *	2013-10-29	2014-11-10	Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон")	ПРИМЕНЕНИЕ БРОМИДА 1-β-ФЕНИЛЭТИЛ)-4-АМИНО-1,2,4-ТРИАЗОЛИЯ (ГИПЕРТРИЛ) КАК АКТИВНОЙ ОСНОВЫ ЛЕКАРСТВЕННЫХ СРЕДСТВ ДЛЯ КОРРЕКЦИИ НАРУШЕНИЙ ФУНКЦИОНИРОВАНИЯ НИТРОКСИДЕРГИЧЕСКОЙ СИСТЕМЫ ОРГАНОВ-МИШЕНЕЙ ПРИ ГОМОЦИСТЕИНЕМИИ И ОСТРЫХ НАРУШЕНИЯХ МОЗГОВОГО КРОВООБРАЩЕНИЯ
WO2016033285A1 (en) *	2014-08-29	2016-03-03	E. I. Du Pont De Nemours And Company	Herbicidal triazoles
KR102512548B1 (ko)	2017-12-22	2023-03-22	삼성디스플레이 주식회사	유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
US12065411B1 (en) *	2023-10-23	2024-08-20	King Faisal University	Methyl 4-((5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)methyl)benzoate as an antimicrobial compound
US11912670B1 (en)	2023-10-25	2024-02-27	King Faisal University	Ethyl 4-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)butanoate as an antimicrobial compound
CN118026948A (zh) *	2024-01-31	2024-05-14	中国药科大学	三联芳环类化合物及其制备方法、药物组合物和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1579352A (en) *	1977-05-06	1980-11-19	Lepetit Spa	3,5-disubstituted-1h-1,2,4-triazoles
DE19643037A1 (de) *	1996-10-18	1998-04-23	Boehringer Ingelheim Kg	Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
US6121260A (en) *	1997-07-03	2000-09-19	Neurogen Corporation	Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives
DE19816880A1 (de) *	1998-04-17	1999-10-21	Boehringer Ingelheim Pharma	Neue Diphenyl-substituierte 5-Ring-Heterocyclen, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
US7487474B2 (en)	2003-01-02	2009-02-03	Pdf Solutions, Inc.	Designing an integrated circuit to improve yield using a variant design element

2000
- 2000-07-13 EP EP00114183A patent/EP1070708B1/en not_active Expired - Lifetime
- 2000-07-13 PT PT00114183T patent/PT1070708E/pt unknown
- 2000-07-13 ES ES00114183T patent/ES2211420T3/es not_active Expired - Lifetime
- 2000-07-13 DK DK00114183T patent/DK1070708T3/da active
- 2000-07-13 DE DE60007697T patent/DE60007697T2/de not_active Expired - Fee Related
- 2000-07-13 AT AT00114183T patent/ATE257827T1/de not_active IP Right Cessation
- 2000-07-17 PE PE2000000707A patent/PE20010349A1/es not_active Application Discontinuation
- 2000-07-17 CA CA002314009A patent/CA2314009C/en not_active Expired - Fee Related
- 2000-07-17 NZ NZ505766A patent/NZ505766A/en unknown
- 2000-07-17 AU AU48651/00A patent/AU773463B2/en not_active Ceased
- 2000-07-17 IL IL13732800A patent/IL137328A0/xx unknown
- 2000-07-18 SG SG200003981A patent/SG98422A1/en unknown
- 2000-07-19 ID IDP20000607D patent/ID26599A/id unknown
- 2000-07-19 AR ARP000103702A patent/AR024790A1/es active IP Right Grant
- 2000-07-19 TR TR2000/02097A patent/TR200002097A3/tr unknown
- 2000-07-19 MA MA26026A patent/MA26747A1/fr unknown
- 2000-07-19 CO CO00054541A patent/CO5190713A1/es not_active Application Discontinuation
- 2000-07-19 MX MXPA00007069A patent/MXPA00007069A/es unknown
- 2000-07-19 US US09/619,518 patent/US6265426B1/en not_active Expired - Fee Related
- 2000-07-20 UY UY26253A patent/UY26253A1/es not_active Application Discontinuation
- 2000-07-20 KR KR10-2000-0041592A patent/KR100383776B1/ko not_active Expired - Fee Related
- 2000-07-20 NO NO20003723A patent/NO20003723L/no unknown
- 2000-07-20 ZA ZA200003680A patent/ZA200003680B/xx unknown
- 2000-07-20 HR HR20000482A patent/HRP20000482A2/hr not_active Application Discontinuation
- 2000-07-20 CN CNB001201816A patent/CN1148357C/zh not_active Expired - Fee Related
- 2000-07-20 HU HU0002792A patent/HUP0002792A3/hu unknown
- 2000-07-21 JP JP2000220748A patent/JP3628946B2/ja not_active Expired - Fee Related
- 2000-07-21 BR BR0003075-9A patent/BR0003075A/pt not_active Application Discontinuation
- 2000-07-21 PL PL00341616A patent/PL341616A1/xx not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR0003075A (pt)	2001-03-13
AU4865100A (en)	2001-01-25
AU773463B2 (en)	2004-05-27
PT1070708E (pt)	2004-05-31
CO5190713A1 (es)	2002-08-29
US6265426B1 (en)	2001-07-24
ATE257827T1 (de)	2004-01-15
NZ505766A (en)	2002-03-28
PE20010349A1 (es)	2001-03-26
JP2001064263A (ja)	2001-03-13
PL341616A1 (en)	2001-01-29
EP1070708A1 (en)	2001-01-24
CN1148357C (zh)	2004-05-05
DE60007697D1 (de)	2004-02-19
TR200002097A2 (tr)	2001-02-21
NO20003723L (no)	2001-01-22
UY26253A1 (es)	2000-10-31
CA2314009C (en)	2008-09-30
EP1070708B1 (en)	2004-01-14
HUP0002792A3 (en)	2002-10-28
MXPA00007069A (es)	2002-04-24
KR100383776B1 (ko)	2003-05-12
CA2314009A1 (en)	2001-01-21
TR200002097A3 (tr)	2001-02-21
CN1281852A (zh)	2001-01-31
SG98422A1 (en)	2003-09-19
AR024790A1 (es)	2002-10-23
HU0002792D0 (en)	2000-09-28
ZA200003680B (en)	2001-01-22
DK1070708T3 (da)	2004-05-10
DE60007697T2 (de)	2004-12-09
ES2211420T3 (es)	2004-07-16
HUP0002792A2 (hu)	2001-09-28
ID26599A (id)	2001-01-25
MA26747A1 (fr)	2004-12-20
IL137328A0 (en)	2001-07-24
KR20010049825A (ko)	2001-06-15
HRP20000482A2 (en)	2001-06-30
JP3628946B2 (ja)	2005-03-16

Publication	Publication Date	Title
DE60007697D1 (de)	2004-02-19	Triazolderivate
NO20006267D0 (no)	2000-12-11	Imidazolyl-derivater
ATE244236T1 (de)	2003-07-15	Substituierte azole
IS6662A (is)	2002-12-19	Imídasól afleiður
NO20025517L (no)	2002-11-18	Triazolderivater
ATE360620T1 (de)	2007-05-15	Imidazolderivate
NO20021690D0 (no)	2002-04-10	Benzodiazepin-derivater
AU7314200A (en)	2001-04-24	Benzimidazole derivatives
ATE360618T1 (de)	2007-05-15	Pyrazolderivate
FI971234A7 (fi)	1997-05-23	Imidatsolijohdannainen
ATE246700T1 (de)	2003-08-15	Benzimidazolderivate
DE60032898D1 (de)	2007-02-22	Arylthiazolidindion- und aryloxazolidinderivate
PT1049694E (pt)	2002-09-30	Derivados de benzoxadiazoles benzotiadiazoles benzotriazoles e quinoxalinas
DK1171437T3 (da)	2004-02-02	Pesticid-indazol- eller -benzotriazolderivater
NO993628D0 (no)	1999-07-26	Pyrazol-derivater
NO20004511L (no)	2001-03-12	Triazolderivater med antifungal aktivitet
ATE250025T1 (de)	2003-10-15	Hydrazin-derivate
DE69915835D1 (de)	2004-04-29	Imidazol-derivate
SI1224180T1 (en)	2003-12-31	Substituted azoles